Harvard Bioscience Schedules Third Quarter 2021 Earnings Conference Call for November 3, 2021 at 8:00 AM ET
HOLLISTON, Mass., Oct. 18, 2021 (GLOBE NEWSWIRE) — Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce…
Month: October 2021
OpGen Announces Closing of $15 Million Registered Direct Offering
ROCKVILLE, Md., Oct. 18, 2021 (GLOBE NEWSWIRE) — OpGen, Inc. (Nasdaq: OPGN, “OpGen” or the…
Calithera Expands Oncology Pipeline with Acquisition of Two Clinical-Stage Assets from Takeda Pharmaceuticals
— TORC 1/2 inhibitor sapanisertib and SYK inhibitor mivavotinib strengthen Company’s precision oncology pipeline —…
Angion to Present Multiple Posters at Kidney Week 2021
UNIONDALE, N.Y., Oct. 18, 2021 (GLOBE NEWSWIRE) — Angion Biomedica Corp (NASDAQ:ANGN), a late-stage biopharmaceutical…
Paratek Pharmaceuticals Announces Enrollment of First Patient in Phase 2b Study Evaluating NUZYRA® (omadacycline) for Nontuberculous Mycobacterial (NTM) Pulmonary Disease Caused by Mycobacterium abscessus Complex (MABc)
— Potential $1 Billion Addressable Market Opportunity in the United States BOSTON, Oct. 18, 2021…
Entasis Therapeutics announces positive topline results for sulbactam-durlobactam (SUL-DUR) from Phase 3 ATTACK trial
SUL-DUR first to achieve statistical non-inferiority in 28-day all-cause mortality in carbapenem-resistant Acinetobacter (CRAB) patients…
Terns Pharmaceuticals to Present Positive Clinical Data on NASH Programs at AASLD The Liver Meeting® Digital Experience 2021
FOSTER CITY, Calif., Oct. 18, 2021 (GLOBE NEWSWIRE) — Terns Pharmaceuticals, Inc. (“Terns” or the…
Iovance Biotherapeutics to Host Conference Call and Webcast to Highlight Data at Society for Immunotherapy of Cancer (SITC) Annual Meeting
Oral Presentation of Clinical Data for TIL in Combination with Pembrolizumabin Immune-Checkpoint Inhibitor Naïve Patients…
Radionetics Oncology Emerges from Crinetics Pharmaceuticals with a Platform and Deep Pipeline of Nonpeptide Targeted Radiopharmaceutical Drug Candidates for Precision Oncology
Co-founded by Crinetics, 5AM Ventures and Frazier Healthcare Partners, the New Company Launches with $30M…
Inventiva announces the presentation of five scientific abstracts at the AASLD The Liver Meeting™ 2021
Four poster presentations add to the evidence of the beneficial effects of lanifibranor therapy on…
PAOG To Launch Second CBD Nutraceutical Product Later This Week Further Ramping Up 2021 Revenue Potential
Sandusky, OH, Oct. 18, 2021 (GLOBE NEWSWIRE) — PAO Group, Inc. (OTC Pink: PAOG) earlier…
AB Science granted authorization from the French Health Authority (ANSM) to initiate a study of AB8939 in the treatment of Acute Myeloid Leukemia (AML)
PRESS RELEASE AB SCIENCE GRANTED AUTHORIZATION FROM THE FRENCH HEALTH AUTHORITY (ANSM) TO INITIATE…
Virbac: excellent revenue growth of 21.2% at the end of September at comparable exchange rates and scope (+16.4% at constant rates and real scope), driven by a very solid third-quarter performance again in all areas
KEY FIGURES RevenueYear-to-date September 30, 2021 €817.7 million At constant exchange rates and scope1 +21.2%…
Alphageneron Announces Successful Completion of FDA Pre-IND Meeting of Proposed Phase II Clinical Trial for NK Cell Therapy with Advanced (stage III & Stage IV) NSCLC Patients
CAMBRIDGE, Mass., Oct. 18, 2021 (GLOBE NEWSWIRE) — Alphageneron Pharmaceuticals, Inc. (“Alphageneron” or the “Company”),…
Aible Launches New Products That Empower Enterprises Wherever They Are On Their AI Journey
Aible features partnership with Boomi and customer stories at Gartner IT Symposium/Xpo™ 2021 PLEASANTON, Calif.,…
Telefónica Tech and Fortinet launch global Secure SD-WAN service to secure and connect work-from-anywhere
The two companies are expanding their strategic alliance to provide an integrated offering of network…
Myanmar Government to Re-Open Schools, Revive Economy and Support Currency to Overcome ‘Triple Crisis Situations’ of Pandemic, Economic Slowdown and Issues of National Stability
Nay Pyi Taw, Oct 19, 2021 – (ACN Newswire) – The Myanmar Government announced today…
Avance Clinical Client News: XWPharma Initiates First-in-Human Studies of XW10508, in Development for Fast-acting Relief of Treatment-Resistant Depression and Chronic Pain
ADELAIDE, AUS, Oct 19, 2021 – (ACN Newswire) – Avance Clinical, the largest premium Australian…
Agilex Biolabs Shares How to Select the Right Bioanalytical Tools for Immuno-oncology and Vaccines Studies – OCT Webinar
ADELAIDE, AUS, Oct 19, 2021 – (ACN Newswire) – Agilex Biolabs, the Australian regulated bioanalytical…
Mitsubishi Power Receives Order of Two Gas Turbines for the Hunter Power Project in Australia
TOKYO, Oct 19, 2021 – (JCN Newswire) – Mitsubishi Power, a power solutions brand of…